Director of the Triumph Program
Silver Hill Hospital
New Canaan, CT, United States
Doctor Emily E. Haas graduated from medical school at the University of Wisconsin School of Medicine and Public Health. She completed her psychiatry residency at the University of Maryland/Sheppard Pratt Psychiatry Residency Program, where she served as chief resident and simultaneously completed a fellowship with the Washington Baltimore Center for Psychoanalysis. After residency, Dr. Haas worked as an attending psychiatrist at the world-renowned Trauma Disorders Unit at Sheppard Pratt Hospital, where she gained expertise in the treatment of complex trauma and dissociative disorders. Dr. Haas was promoted to the role of Co-Service Chief of the Trauma Disorders Unit where she worked collaboratively with a multidisciplinary team to provide treatment to patients with complex trauma and dissociative disorders from across the world. In this role, Dr. Haas has had the privilege of treating hundreds of patients with severe dissociative disorders, many of whom have struggled with significant dysregulation and severe levels of unsafety.
Dr. Haas is recognized as an expert in the treatment of dissociative disorders. In the fall of 2022, Dr. Haas brought her expertise to Silver Hill Hospital where she developed, and is the Director of, the Triumph Program, a residential program for the treatment of complex trauma and dissociative disorders. In her role as Director of the Triumph Program, Dr. Haas runs one of the few residential programs in the United States able to safely and effectively treat individuals with Dissociative Identity Disorder.
Dr. Haas has led grand rounds, presented nationally, created psychiatry residency curriculums, and provided local workshops on topics related to the treatment of individuals with complex trauma and dissociation. Dr. Haas is the recipient of the Clarence G. Schulz award from Sheppard Pratt Health System and the Scott Schwartz award from the American Academy of Psychodynamic Psychiatry and Psychoanalysis.
Disclosure information not submitted.
Friday, March 27, 2026
1:30 PM - 5:00 PM US Pacific Time